Curaleaf Boosts International Presence With Another Cannabis Acquisition
Curaleaf Boosts International Presence With Another Cannabis Acquisition
Cannabis giant Curaleaf Holdings, Inc. (TSX:CURA) (OTCQX:CURLF) is closing its previously announced acquisition of Northern Green Canada, a vertically integrated Canadian licensed cannabis producer focused primarily on expanding in the international market through its EU-GMP certification.
大麻巨頭Curaleaf Holdings, Inc.（多倫多證券交易所股票代碼：CURA）（OTCQX: CURLF）即將完成先前宣佈的對加拿大北方綠色公司的收購。加拿大北方綠色公司是一家垂直整合的加拿大持牌大麻生產商，主要專注於通過其歐盟GMP認證在國際市場進行擴張。
Terms of the acquisition of NGC include an initial payment at closing of the company's subordinate voting shares valued at approximately $16 million, subject to a typical post-closing adjustment.
收購NGC的條款包括在收盤時首次支付公司價值約1,600萬美元的附屬有表決權股票，但需進行典型的收盤後調整。
In addition, an earnout may also be paid in 2025 based upon the 2024 performance of NGC's operations, up to 50% of which will be cash and the rest paid in additional subordinate voting shares.
此外，還可能根據NGC2024年的運營業績在2025年支付收益，其中高達50％將是現金，其餘的將以額外的次級有表決權的股份支付。
Why It Matters
爲什麼重要
The deal boosts Curaleaf's strategic advantage in established European markets including Germany, Poland and the United Kingdom while providing a foothold in the emerging markets of Australia and New Zealand, the company said on Monday in a press release.
該公司週一在一份新聞稿中表示，該交易增強了Curaleaf在包括德國、波蘭和英國在內的歐洲成熟市場的戰略優勢，同時爲澳大利亞和新西蘭的新興市場提供了立足點。
"The global cannabis market is projected to generate $55 billion in sales by 2027. Emerging markets beyond the United States and Canada, including Germany, Australia and New Zealand are expected to contribute $6.3 billion of the $55 billion projection," the company said.
“預計到2027年，全球大麻市場將創造550億美元的銷售額。該公司表示，預計的550億美元中，美國和加拿大以外的新興市場，包括德國、澳大利亞和新西蘭，預計將貢獻63億美元。
Given NGC's longstanding role as a key supplier to Curaleaf's Four20 brand, this acquisition marks a significant milestone in Curaleaf's expansion strategy, particularly in Europe.
鑑於NGC長期以來一直是Curaleaf的Four20品牌的主要供應商，此次收購標誌着Curaleaf擴張戰略中的一個重要里程碑，尤其是在歐洲。
"We are thrilled to welcome NGC formally to the Curaleaf family of global brands," Boris Jordan, founder and executive chairman of Curaleaf, said. "This is an incredibly important deal for our international expansion strategy, as we'll be able to bolster our supply of high-quality EU-GMP certified flower immediately to key European markets as well as enter the fast-growing markets of Australia and New Zealand."
Curaleaf創始人兼執行董事長鮑里斯·喬丹說：“我們很高興歡迎NGC正式加入Curaleaf全球品牌家族。”“這對我們的國際擴張戰略來說是一筆非常重要的交易，因爲我們將能夠立即增加向主要歐洲市場供應高質量的歐盟GMP認證花卉，並進入澳大利亞和新西蘭快速增長的市場。”
Curaleaf In Germany
德國的 Curaleaf
Jordan recently told the crowd gathered at the Benzinga Cannabis Capital Conference in Florida that Curaleaf is seeing positive trends following cannabis legalization in Germany.
喬丹最近告訴聚集在佛羅里達州本辛加大麻資本會議上的群衆，在德國大麻合法化之後，Curaleaf看到了積極的趨勢。
In the first two weeks that cannabis was removed from the narcotics lists, there has been a five-fold increase in patients approaching telemedicine platforms, he said, suggesting cannabis demand is rising quickly.
他說，在大麻被從毒品清單中刪除的前兩週內，使用遠程醫療平台的患者增加了五倍，這表明大麻需求正在迅速上升。
The new law that legalized cannabis partially in Germany took effect on Monday, April 1, making it the third country in Europe to legalize adult-use marijuana after Malta and Luxembourg.
在德國部分合法化大麻的新法律於4月1日星期一生效，使其成爲繼馬耳他和盧森堡之後歐洲第三個將成人用大麻合法化的國家。
See also: Curaleaf Poised To Dominate German Cannabis Market As Government Moves To Legalize
另見：隨着政府開始合法化，Curaleaf有望主導德國大麻市場
CURLF Price Action
CURLF 價格走勢
Curaleaf's shares traded 1.21% lower at $4.88 per share at the time of writing on Monday morning.
在週一上午撰寫本文時，Curaleaf的股價下跌1.21％，至每股4.88美元。
譯文內容由第三人軟體翻譯。